BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
June 22, 2004
View Archived Issues
Titan Halts Phase II Studies Of Pivanex In NSCL Cancer
Safety concerns prompted Titan Pharmaceuticals Inc. to stop a year-old Phase IIb study of its cancer drug Pivanex. (BioWorld Today)
Read More
Neurochem Enters Phase III Alzhemed Alzheimer's Trial
Read More
As BioShield Signing Nears, BioShield II Planning Begins
Read More
Tercica Plans NDA Filing After Positive Phase III rhIGF-1 Data
Read More
Other News To Note
Read More
Appointments And Advancements
Read More